34 results
253G2
IGXT
IntelGenx Technologies Corp.
20 Feb 24
Offering circular supplement
2:07pm
VersaFilm™ technology is intended for indications requiring rapid onset of action, such as migraine, opioid dependence, chronic pain, motion sickness
424B5
no5uryh
18 Oct 18
Prospectus supplement for primary offering
9:48pm
424B5
przrvehi 1bj42
17 Oct 18
Prospectus supplement for primary offering
4:17pm
S-3/A
jfbg3yaxhly3x1z9w3
4 Oct 18
Shelf registration (amended)
5:28pm
S-3
ngia18p9i309xssmq
24 Sep 18
Shelf registration
1:59pm